Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

2.

Risk of prenatal depression and stress treatment: alteration on serotonin system of offspring through exposure to Fluoxetine.

Pei S, Liu L, Zhong Z, Wang H, Lin S, Shang J.

Sci Rep. 2016 Oct 5;6:33822. doi: 10.1038/srep33822.

3.

Selective serotonin reuptake inhibitors and pregnancy: A review of maternal, fetal and neonatal risks and benefits.

Marchocki Z, Russell NE, Donoghue KO.

Obstet Med. 2013 Dec;6(4):155-8. doi: 10.1177/1753495X13495194. Epub 2013 Aug 8. Review.

4.

Insomnia during pregnancy: Diagnosis and Rational Interventions.

Hashmi AM, Bhatia SK, Bhatia SK, Khawaja IS.

Pak J Med Sci. 2016 Jul-Aug;32(4):1030-7. doi: 10.12669/pjms.324.10421. Review.

5.

Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 6. Special Populations: Youth, Women, and the Elderly.

MacQueen GM, Frey BN, Ismail Z, Jaworska N, Steiner M, Lieshout RJ, Kennedy SH, Lam RW, Milev RV, Parikh SV, Ravindran AV; CANMAT Depression Work Group..

Can J Psychiatry. 2016 Sep;61(9):588-603. doi: 10.1177/0706743716659276. Epub 2016 Aug 2.

6.

Of rodents and humans: A comparative review of the neurobehavioral effects of early life SSRI exposure in preclinical and clinical research.

Glover ME, Clinton SM.

Int J Dev Neurosci. 2016 Jun;51:50-72. doi: 10.1016/j.ijdevneu.2016.04.008. Epub 2016 May 7. Review.

PMID:
27165448
7.

Maternal Use of Selective Serotonin Reuptake Inhibitors and Lengthening of the Umbilical Cord: Indirect Evidence of Increased Foetal Activity-A Retrospective Cohort Study.

Kivistö J, Lehto SM, Halonen K, Georgiadis L, Heinonen S.

PLoS One. 2016 Apr 29;11(4):e0154628. doi: 10.1371/journal.pone.0154628. eCollection 2016.

8.

Developmental changes in serotonin signaling: Implications for early brain function, behavior and adaptation.

Brummelte S, Mc Glanaghy E, Bonnin A, Oberlander TF.

Neuroscience. 2017 Feb 7;342:212-231. doi: 10.1016/j.neuroscience.2016.02.037. Epub 2016 Feb 22. Review.

9.

Maternal psychiatric disorders and risk of preterm birth.

Männistö T, Mendola P, Kiely M, O'Loughlin J, Werder E, Chen Z, Ehrenthal DB, Grantz KL.

Ann Epidemiol. 2016 Jan;26(1):14-20. doi: 10.1016/j.annepidem.2015.09.009. Epub 2015 Oct 23.

10.

Trends and Determinants of Prescription Drug Use during Pregnancy and Postpartum in British Columbia, 2002-2011: A Population-Based Cohort Study.

Smolina K, Hanley GE, Mintzes B, Oberlander TF, Morgan S.

PLoS One. 2015 May 26;10(5):e0128312. doi: 10.1371/journal.pone.0128312. eCollection 2015.

11.

Behavioural effects of fetal antidepressant exposure in a Norwegian cohort of discordant siblings.

Brandlistuen RE, Ystrom E, Eberhard-Gran M, Nulman I, Koren G, Nordeng H.

Int J Epidemiol. 2015 Aug;44(4):1397-407. doi: 10.1093/ije/dyv030. Epub 2015 Apr 14.

12.

The effect of antenatal depression and selective serotonin reuptake inhibitor treatment on nerve growth factor signaling in human placenta.

Kaihola H, Olivier J, Poromaa IS, Åkerud H.

PLoS One. 2015 Jan 22;10(1):e0116459. doi: 10.1371/journal.pone.0116459. eCollection 2015.

13.

Perinatal vs genetic programming of serotonin states associated with anxiety.

Altieri SC, Yang H, O'Brien HJ, Redwine HM, Senturk D, Hensler JG, Andrews AM.

Neuropsychopharmacology. 2015 May;40(6):1456-70. doi: 10.1038/npp.2014.331. Epub 2014 Dec 19.

14.

Prenatal depression and adverse birth outcomes: an updated systematic review.

Accortt EE, Cheadle AC, Dunkel Schetter C.

Matern Child Health J. 2015 Jun;19(6):1306-37. doi: 10.1007/s10995-014-1637-2. Review.

15.

Preconception care: screening and management of chronic disease and promoting psychological health.

Lassi ZS, Imam AM, Dean SV, Bhutta ZA.

Reprod Health. 2014 Sep 26;11 Suppl 3:S5. doi: 10.1186/1742-4755-11-S3-S5. Epub 2014 Sep 26. Review.

16.

Computer-assisted cognitive behavioral therapy for pregnant women with major depressive disorder.

Kim DR, Hantsoo L, Thase ME, Sammel M, Epperson CN.

J Womens Health (Larchmt). 2014 Oct;23(10):842-8. doi: 10.1089/jwh.2014.4867. Epub 2014 Sep 30.

17.

Treatment of nonpsychotic major depression during pregnancy: patient safety and challenges.

Epstein RA, Moore KM, Bobo WV.

Drug Healthc Patient Saf. 2014 Sep 18;6:109-29. doi: 10.2147/DHPS.S43308. eCollection 2014. Review.

18.

Monoamine-sensitive developmental periods impacting adult emotional and cognitive behaviors.

Suri D, Teixeira CM, Cagliostro MK, Mahadevia D, Ansorge MS.

Neuropsychopharmacology. 2015 Jan;40(1):88-112. doi: 10.1038/npp.2014.231. Epub 2014 Sep 2. Review.

19.

Prenatal antidepressant exposure is associated with risk for attention-deficit hyperactivity disorder but not autism spectrum disorder in a large health system.

Clements CC, Castro VM, Blumenthal SR, Rosenfield HR, Murphy SN, Fava M, Erb JL, Churchill SE, Kaimal AJ, Doyle AE, Robinson EB, Smoller JW, Kohane IS, Perlis RH.

Mol Psychiatry. 2015 Jun;20(6):727-34. doi: 10.1038/mp.2014.90. Epub 2014 Aug 26.

20.

Patterns of psychotropic medicine use in pregnancy in the United States from 2006 to 2011 among women with private insurance.

Hanley GE, Mintzes B.

BMC Pregnancy Childbirth. 2014 Jul 22;14:242. doi: 10.1186/1471-2393-14-242.

Supplemental Content

Support Center